Formulation development is Rubicon Research’s core competency and we routinely carry out development of generic formulations, specialty and novel formulations, consumer, and over-the-counter (OTC) formulations with desired sensorial attributes, excipient application studies, and placebo development.
Product development at Rubicon Research begins with product strategy development. Desired product attributes are identified and prototype formulations are developed to meet the desired product attributes. Critical process parameters (CPP) are identified and process optimization studies are carried out based on Quality by Design (QbD) principles. Based on the formula and process optimization studies, final composition and manufacturing process is recommended for bio study and scale-up.
Activities include
Rubicon Research can develop
See our diverse dosage forms handling capability here.
Rubicon Research Private Limited
MedOne House, Plot No. B-75,
Road No. 33, Wagle Estate,
Thane (W) 400604,
Maharashtra, India
Contact: +91 22 61414000
Rubicon Research Private Limited
Plot no. K 30/4 & 30/5,
Additional MIDC, Ambernath,
District Thane 421 506,
Maharashtra, India
Contact: +91 251 2628100
Rubicon Research Private Limited
Suite 605, Princeton Office Center II,
666 Plainsboro Road, Plainsboro,
New Jersey 08536
United States of America
Rubicon Research Canada Limited
255 Spinnaker Way,
Unit 6, Concord,
Ontario, L4K 4J1,
Canada
Rubicon Consumer Healthcare Private Limited
MedOne House, Plot No. B-75,
Road No. 33, Wagle Estate,
Thane (W) 400604,
Maharashtra, India
Contact: +91 22 61414000
Rubicon Academy LLP
MedOne House, Plot No. B-75,
Road No. 33, Wagle Estate,
Thane (W) 400604,
Maharashtra, India
Contact: +91 22 61414000